OBIO

Bullish

OBIO: Upcoming BackBeat and Virtue trial milestones signal strong growth and partnership-driven value

Orchestra BioMed (OBIO) is focused on a partnership-driven model for R&D and clinical trials, particularly in hypertension therapy and drug delivery. ...

TradingView 2 weeks ago 0

Bullish

New hires at Orchestra BioMed receive options on 85,500 shares

Orchestra BioMed (Nasdaq: OBIO) announced that its compensation committee granted stock options for a total of 85,500 common shares to five new employ...

Stock Titan 2 weeks ago 0